118 related articles for article (PubMed ID: 2118879)
21. [Changes of neopterin in cerebrospinal fluid and serum in children with meningitis].
Kawakami Y; Fukunaga Y; Hashimoto K
No To Hattatsu; 1996 Jan; 28(1):23-9. PubMed ID: 8579853
[TBL] [Abstract][Full Text] [Related]
22. Correlation of clinical and immunological parameters of metastatic renal cell carcinoma patients undergoing therapy with interleukin 2, interferon-alpha and retinoic acid.
Elsässer-Beile U; Kölble N; Grussenmeyer T; Wetterauer U; Schultze-Seemann W
Anticancer Res; 1998; 18(3B):1883-90. PubMed ID: 9677439
[TBL] [Abstract][Full Text] [Related]
23. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
[TBL] [Abstract][Full Text] [Related]
24. Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).
Aulitzky WE; Grosse-Wilde H; Westhoff U; Tilg H; Aulitzky W; Gastl G; Herold M; Huber C
Clin Exp Immunol; 1991 Nov; 86(2):236-9. PubMed ID: 1934591
[TBL] [Abstract][Full Text] [Related]
25. Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2.
Aulitzky WE; Tilg H; Vogel W; Aulitzky W; Berger M; Gastl G; Herold M; Huber C
Ann Hematol; 1991 Feb; 62(1):25-31. PubMed ID: 1903309
[TBL] [Abstract][Full Text] [Related]
26. Cytokine release from cultured peripheral blood mononuclear cells of patients with severe atopic dermatitis.
Reinhold U; Pawelec G; Wehrmann W; Kukel S; Oehr P; Kreysel HW
Acta Derm Venereol; 1989; 69(6):497-502. PubMed ID: 2575322
[TBL] [Abstract][Full Text] [Related]
27. Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.
Beniers AJ; van Moorselaar RJ; Peelen WP; Debruyne FM; Schalken JA
Urol Res; 1991; 19(2):91-8. PubMed ID: 1906659
[TBL] [Abstract][Full Text] [Related]
28. Daily alternating administration of high-dose alpha-2b-interferon and interleukin-2 bolus infusion in metastatic renal cell cancer. A phase II study.
Bergmann L; Fenchel K; Weidmann E; Enzinger HM; Jahn B; Jonas D; Mitrou PS
Cancer; 1993 Sep; 72(5):1733-42. PubMed ID: 8348502
[TBL] [Abstract][Full Text] [Related]
29. Cytokine induction of neopterin production.
Henderson DC; Sheldon J; Riches P; Hobbs JR
Clin Exp Immunol; 1991 Mar; 83(3):479-82. PubMed ID: 1825941
[TBL] [Abstract][Full Text] [Related]
30. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of continuous subcutaneous infusion therapy using interferon alpha and the possible prognostic indicator of TNF-alpha in renal cell carcinoma.
Matsuyama H; Yamamoto M; Yoshihiro S; Ohmoto Y; Naito K
Int J Urol; 1997 Sep; 4(5):447-50. PubMed ID: 9354944
[TBL] [Abstract][Full Text] [Related]
32. Neopterin release from human endothelial cells is triggered by interferon-gamma.
Andert SE; Griesmacher A; Zuckermann A; Müller MM
Clin Exp Immunol; 1992 Jun; 88(3):555-8. PubMed ID: 1606740
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma.
Kopp WC; Smith JW; Ewel CH; Alvord WG; Main C; Guyre PM; Steis RG; Longo DL; Urba WJ
J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):181-90. PubMed ID: 8471592
[TBL] [Abstract][Full Text] [Related]
34. Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion.
Shaarawy M; Nagui AR
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):205-11. PubMed ID: 9093132
[TBL] [Abstract][Full Text] [Related]
35. Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoring.
Farace F; Pallardy M; Angevin E; Hercend T; Escudier B; Triebel F
Int J Cancer; 1994 Jun; 57(6):814-21. PubMed ID: 8206677
[TBL] [Abstract][Full Text] [Related]
36. Cyclic interferon gamma treatment of patients with metastatic renal carcinoma.
Grups JW; Frohmüller HG
Br J Urol; 1989 Sep; 64(3):218-20. PubMed ID: 2508986
[TBL] [Abstract][Full Text] [Related]
37. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
38. Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.
Boccoli G; Masciulli R; Ruggeri EM; Carlini P; Giannella G; Montesoro E; Mastroberardino G; Isacchi G; Testa U; Calabresi F
Cancer Res; 1990 Sep; 50(18):5795-800. PubMed ID: 2118421
[TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome.
Drenth JP; Powell RJ; Brown NS; Van der Meer JW
Eur J Clin Invest; 1995 Sep; 25(9):683-6. PubMed ID: 7498243
[TBL] [Abstract][Full Text] [Related]
40. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
